Delivery Order SPE2DB24D3013-SPE2DB25FFPPH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $51,571.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (60-count units), a combination inhalation medication used in respiratory disease management. This firm fixed price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,298.96 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol used to treat chronic obstructive pulmonary disease. The order, placed on August 18, 2025, with an ultimate completion date of August 19, 2025, was competitively awarded without set-aside designation under firm fixed-price terms. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,251.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used in respiratory disease treatment. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,930.97 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product for respiratory treatment. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $27,169.72 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $18,103.28 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhaler, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed price delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a non-competitive award under the company's existing contract vehicle. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $21,739.01 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, with an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,753.67 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used in respiratory disease management. The contract is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $11,167.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,007.60 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used for chronic...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFPPHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,713.43 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol. This firm fixed-price, non-set-aside delivery order was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction through the company's established federal contracting relationships. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The DLA has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among potential vendors serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible contracting arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 8/19/25 |